Eris Lifesciences Ltd
Glimepiride (2mg) + Metformin (1000mg) + Voglibose (0.mg)
Glimisave MV 2.2F Tablet SR is an anti-diabetic drug used to treat type 2 diabetes mellitus in adults by controlling blood sugar levels.
Tablet SR
Glimisave MV 2.2F Tablet SR is a combination of medicines used to treat type 2 diabetes mellitus in adults. It helps control blood sugar levels in people with diabetes. This medication should be taken with food to avoid stomach upset and can cause hypoglycemia when used with other antidiabetic medicines, alcohol, or if meals are delayed or missed. Regular liver function checks are recommended. Consult your doctor for more information.
Take this medicine in the dose and duration as advised by your doctor. Swallow it as a whole. Do not chew, crush, or break it. Glimisave MV 2.2F Tablet SR is to be taken on an empty stomach.
Glimisave MV 2.2F Tablet SR is a combination of three antidiabetic medicines.
Take it with food to lower your chance of having an upset stomach. It can cause hypoglycemia (low blood sugar level) when used with other antidiabetic medicines, alcohol, or if you delay or miss a meal. Carry a sugar source with you for immediate relief. Your doctor may check your liver function regularly. Inform your doctor if you develop symptoms such as abdominal pain, loss of appetite, or yellowing of the eyes or skin (jaundice).
Glimisave MV 2.2F Tablet SR is a combination medication containing glimepiride, metformin, and voglibose. It is used to treat type 2 diabetes mellitus (DM) in adults, in combination with a healthy diet and regular exercise. Glimepiride increases insulin release from the pancreas, metformin lowers glucose production in the liver and improves insulin sensitivity, and voglibose reduces postprandial glucose levels. This medication is not suitable for treating type 1 DM. Consult your doctor for personalized advice.
Common side effects of Glimisave MV 2.2F Tablet SR include hypoglycemia (low blood sugar), nausea, diarrhea, altered taste, flatulence, stomach pain, headache, skin rash, and respiratory tract infection. If you experience any unusual symptoms, consult your doctor or a qualified healthcare professional.
Glimisave MV 2.2F Tablet SR is contraindicated in patients with known allergies to its components or excipients, moderate to severe kidney disease, inflammatory bowel disease, colonic ulcerations, and underlying metabolic acidosis, including diabetic ketoacidosis. Consult your doctor before taking this medication if you have any underlying medical conditions.
No, it is not recommended to consume alcohol while taking Glimisave MV 2.2F Tablet SR. This may increase the risk of hypoglycemia and lactic acidosis. Avoid drinking alcohol while taking this medication and consult your doctor for personalized advice.
Yes, Glimisave MV 2.2F Tablet SR can cause hypoglycemia (low blood sugar). Symptoms of hypoglycemia include nausea, headache, irritability, hunger, sweating, dizziness, fast heart rate, and feeling anxious or shaky. Regularly monitor your blood sugar levels and take steps to prevent hypoglycemia, such as eating regular meals, avoiding excessive exercise, and keeping glucose tablets or other quick-acting carbohydrates nearby. Consult your doctor for personalized advice on managing hypoglycemia.
Store Glimisave MV 2.2F Tablet SR in its original packaging, tightly closed, according to the instructions on the packaging or label. Dispose of any unused medication and ensure it is not consumed by pets, children, or other individuals. Consult your pharmacist or doctor for guidance on proper disposal and storage.